إعلان
إعلان

MNOV

MNOV logo

Medicinova, Inc.

1.43
USD
برعاية
+0.03
+2.14%
٠٨ يناير, ١٥:٥١ UTC -5
مغلق
exchange

بعد الإغلاق

1.43

0.00
-0.35%

تقارير أرباح MNOV

النسبة الإيجابية المفاجئة

MNOV تفوق 28 من 38 آخر التقديرات.

74%

التقرير التالي

بيانات التقرير القادم
١٧ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.11
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
+83.33%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
+83.33%

Medicinova, Inc. earnings per share and revenue

On ١٢ نوفمبر ٢٠٢٥, MNOV reported earnings of -0.06 USD per share (EPS) for Q3 25, beating the estimate of -0.10 USD, resulting in a 41.18% surprise. Revenue reached 123.32 ألف, compared to an expected --, with a --% difference. The market reacted with a -1.91% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of -0.11 USD, with revenue projected to reach -- USD, implying an زيادة of 83.33% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Medicinova, Inc. reported EPS of -$0.06, beating estimates by 41.18%, and revenue of $123.32K, -- -- expectations.
The stock price moved down -1.91%, changed from $1.57 before the earnings release to $1.54 the day after.
The next earning report is scheduled for ١٧ فبراير ٢٠٢٦.
Based on 4 المحللين, Medicinova, Inc. is expected to report EPS of -$0.11 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان